9004-99-3,MFCD00148007
Catalog No.:AA00ILHE

9004-99-3 | Poly(oxy-1,2-ethanediyl), a-(1-oxooctadecyl)-w-hydroxy-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100g
98%
in stock  
$7.00   $5.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00ILHE
Chemical Name:
Poly(oxy-1,2-ethanediyl), a-(1-oxooctadecyl)-w-hydroxy-
CAS Number:
9004-99-3
Molecular Formula:
C20H40O3
Molecular Weight:
328.5298
MDL Number:
MFCD00148007
SMILES:
CCCCCCCCCCCCCCCCCC(=O)OCCO
NSC Number:
31811
Properties
Computed Properties
 
Complexity:
241  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
19  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
7.8  

Literature

Title: Controlling lipolysis through steric surfactants: new insights on the controlled degradation of submicron emulsions after oral and intravenous administration.

Journal: International journal of pharmaceutics 20120227

Title: Thermally-triggered 'off-on-off' response of gadolinium-hydrogel-lipid hybrid nanoparticles defines a customizable temperature window for non-invasive magnetic resonance imaging thermometry.

Journal: Journal of controlled release : official journal of the Controlled Release Society 20120210

Title: Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120123

Title: Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.

Journal: Molecular pharmaceutics 20111003

Title: Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110901

Title: Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations.

Journal: Journal of pharmaceutical sciences 20110201

Title: Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.

Journal: International journal of pharmaceutics 20101215

Title: In vitro drug release mechanism from lipid nanocapsules (LNC).

Journal: International journal of pharmaceutics 20100510

Title: Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society 20090804

Title: Controlled complexation of plasmid DNA with cationic polymers: effect of surfactant on the complexation and stability of the complexes.

Journal: Colloids and surfaces. B, Biointerfaces 20081001

Title: Influence of the dissolution rate on the collapse and shedding behavior of monostearin/monopalmitin-rich coated microbubbles.

Journal: Langmuir : the ACS journal of surfaces and colloids 20080916

Title: Action of Humicola lanuginosa lipase on mixed monomolecular films of tricaprylin and polyethylene glycol stearate.

Journal: Colloids and surfaces. B, Biointerfaces 20080501

Title: Separation and determination of polyethylene glycol fatty acid esters in cosmetics by a reversed-phase HPLC/ELSD.

Journal: Talanta 20080215

Title: Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.

Journal: International journal of pharmaceutics 20080204

Title: Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.

Journal: International journal of pharmaceutics 20071210

Title: Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.

Journal: Colloids and surfaces. B, Biointerfaces 20071115

Title: In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.

Journal: Biomaterials 20061201

Title: Towards a molecular characterization of pharmaceutical excipients: mass spectrometric studies of ethoxylated surfactants.

Journal: International journal of pharmaceutics 20060817

Title: In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages.

Journal: Drug delivery 20060101

Title: [9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20051101

Title: Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.

Journal: International journal of pharmaceutics 20051013

Title: The preparation of orally disintegrating tablets using a hydrophilic waxy binder.

Journal: International journal of pharmaceutics 20040708

Title: [Allergic respiratory disorders and vein sclerosis with lauromacrogol 400].

Journal: Therapie 20040101

Title: The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B.

Journal: The Journal of pharmacy and pharmacology 19910501

Title: Cutler RR, et al. The effect of polyoxyethylene stearate (POES) on the growth of mycobacteria in radiometric 7H12 Middlebrook TB medium. Tubercle. 1987 Sep;68(3):209-20.

Title: Zhu S, et al. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450. Eur J Pharm Sci. 2009 Jul 12;37(5):573-80.

Title: Luo L, et al. Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate. AAPS J. 2007 Oct 5;9(3):E329-35.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:9004-99-3 Molecular Formula|9004-99-3 MDL|9004-99-3 SMILES|9004-99-3 Poly(oxy-1,2-ethanediyl), a-(1-oxooctadecyl)-w-hydroxy-
Catalog No.: AA00ILHE
9004-99-3,MFCD00148007
9004-99-3 | Poly(oxy-1,2-ethanediyl), a-(1-oxooctadecyl)-w-hydroxy-
Pack Size: 100g
Purity: 98%
in stock
$7.00 $5.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00ILHE
Chemical Name: Poly(oxy-1,2-ethanediyl), a-(1-oxooctadecyl)-w-hydroxy-
CAS Number: 9004-99-3
Molecular Formula: C20H40O3
Molecular Weight: 328.5298
MDL Number: MFCD00148007
SMILES: CCCCCCCCCCCCCCCCCC(=O)OCCO
NSC Number: 31811
Properties
Complexity: 241  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 19  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 7.8  
Literature fold

Title: Controlling lipolysis through steric surfactants: new insights on the controlled degradation of submicron emulsions after oral and intravenous administration.

Journal: International journal of pharmaceutics20120227

Title: Thermally-triggered 'off-on-off' response of gadolinium-hydrogel-lipid hybrid nanoparticles defines a customizable temperature window for non-invasive magnetic resonance imaging thermometry.

Journal: Journal of controlled release : official journal of the Controlled Release Society20120210

Title: Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences20120123

Title: Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.

Journal: Molecular pharmaceutics20111003

Title: Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V20110901

Title: Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations.

Journal: Journal of pharmaceutical sciences20110201

Title: Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.

Journal: International journal of pharmaceutics20101215

Title: In vitro drug release mechanism from lipid nanocapsules (LNC).

Journal: International journal of pharmaceutics20100510

Title: Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society20090804

Title: Controlled complexation of plasmid DNA with cationic polymers: effect of surfactant on the complexation and stability of the complexes.

Journal: Colloids and surfaces. B, Biointerfaces20081001

Title: Influence of the dissolution rate on the collapse and shedding behavior of monostearin/monopalmitin-rich coated microbubbles.

Journal: Langmuir : the ACS journal of surfaces and colloids20080916

Title: Action of Humicola lanuginosa lipase on mixed monomolecular films of tricaprylin and polyethylene glycol stearate.

Journal: Colloids and surfaces. B, Biointerfaces20080501

Title: Separation and determination of polyethylene glycol fatty acid esters in cosmetics by a reversed-phase HPLC/ELSD.

Journal: Talanta20080215

Title: Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.

Journal: International journal of pharmaceutics20080204

Title: Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.

Journal: International journal of pharmaceutics20071210

Title: Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.

Journal: Colloids and surfaces. B, Biointerfaces20071115

Title: In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.

Journal: Biomaterials20061201

Title: Towards a molecular characterization of pharmaceutical excipients: mass spectrometric studies of ethoxylated surfactants.

Journal: International journal of pharmaceutics20060817

Title: In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages.

Journal: Drug delivery20060101

Title: [9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica20051101

Title: Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.

Journal: International journal of pharmaceutics20051013

Title: The preparation of orally disintegrating tablets using a hydrophilic waxy binder.

Journal: International journal of pharmaceutics20040708

Title: [Allergic respiratory disorders and vein sclerosis with lauromacrogol 400].

Journal: Therapie20040101

Title: The influence of Myrj 59 on the solubility, toxicity and activity of amphotericin B.

Journal: The Journal of pharmacy and pharmacology19910501

Title: Cutler RR, et al. The effect of polyoxyethylene stearate (POES) on the growth of mycobacteria in radiometric 7H12 Middlebrook TB medium. Tubercle. 1987 Sep;68(3):209-20.

Title: Zhu S, et al. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450. Eur J Pharm Sci. 2009 Jul 12;37(5):573-80.

Title: Luo L, et al. Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate. AAPS J. 2007 Oct 5;9(3):E329-35.

Building Blocks More >
11089-65-9
11089-65-9
Tunicamycin from Streptomyces sp.
AA00ILMT | MFCD00065709
15128-83-3
15128-83-3
2-Methyl-4-nitropyridin-3-ol
AA00IM81 | MFCD18802601
1397202-77-5
1397202-77-5
3-(Diphenylamino)dibenzo[g,p]chrysene
AA00IMCX | MFCD11042679
1984814-41-6
1984814-41-6
Neu5ac alpha(2-6)gal beta mp glycoside
AA00IMGC | MFCD10566922
944129-00-4
944129-00-4
Methyl 6-amino-2-chloropyrimidine-4-carboxylate
AA00IMJO | MFCD14582103
241488-19-7
241488-19-7
methyl 3-{5-[(1E)-(methoxyimino)methyl]furan-2-yl}thiophene-2-carboxylate
AA00IMOE | MFCD00139390
241488-24-4
241488-24-4
1-[4-(1H-pyrazol-5-yl)phenyl]-1,4-dihydropyridin-4-one
AA00IMQZ | MFCD00139310
250714-11-5
250714-11-5
1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
AA00IMUE | MFCD00172470
252026-42-9
252026-42-9
2-[(2,6-dichlorophenyl)sulfanyl]-1,1-diphenylethan-1-ol
AA00IMWY | MFCD00214938
341966-24-3
341966-24-3
ethyl 5-(5-acetyl-3-benzamido-2-oxo-2H-pyran-6-yl)-1,2-oxazole-3-carboxylate
AA00IMZR | MFCD01315897
Submit
© 2017 AA BLOCKS, INC. All rights reserved.